Dr Jamie A Cesaretti, MD, MS - Mount Sinai School of Medicine - Assistant Professor

Dr Jamie A Cesaretti

MD, MS

Mount Sinai School of Medicine

Assistant Professor

New York, NY | United States

Main Specialties: Oncology

Additional Specialties: prostate cancer, breast cancer, lung cancer

Dr Jamie A Cesaretti, MD, MS - Mount Sinai School of Medicine - Assistant Professor

Dr Jamie A Cesaretti

MD, MS

Introduction

Primary Affiliation: Mount Sinai School of Medicine - New York, NY , United States

Specialties:

Additional Specialties:

Research Interests:

Education

May 2006
Mount Sinai School of Medicine
M.S.
Clinical Research
May 2004
Mount Sinai School of Medicine
Residency
Radiation Oncology/Brachytherapy
Jun 2000
St. Lukes Roosevelt Hospital
Internship
Medicine
Jun 1999
SUNY - Stony Brook School of Medicine
M.D.
Medicine
May 1993
Columbia College, Columbia University
B.A.
History

Publications

46Publications

777Reads

86Profile Views

449PubMed Central Citations

The influence of stigma on the quality of life for prostate cancer survivors.

J Psychosoc Oncol 2017 Jul-Aug;35(4):451-467. Epub 2017 Mar 20.

c Southpoint Cancer Center , Jacksonville , FL , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/07347332.2017.1307896DOI Listing
August 2017
13 Reads
1 Citation

Salvage brachytherapy for recurrent prostate cancer.

Brachytherapy 2014 Jan-Feb;13(1):53-8. Epub 2013 Dec 2.

Florida Center for Prostate Care, Jacksonville, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brachy.2013.10.012DOI Listing
May 2014
12 Reads
6 Citations
1.990 Impact Factor

Long-term outcomes and prognostic factors in patients treated with intraoperatively planned prostate brachytherapy.

Brachytherapy 2013 Mar-Apr;12(2):120-5. Epub 2012 Oct 10.

Florida Center for Prostate Care, Jacksonville, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brachy.2012.08.002DOI Listing
August 2013
5 Reads
1 Citation
1.990 Impact Factor

Acceptability and preliminary feasibility of an internet/CD-ROM-based education and decision program for early-stage prostate cancer patients: randomized pilot study.

J Med Internet Res 2012 Jan 13;14(1):e6. Epub 2012 Jan 13.

Mount Sinai School of Medicine, Departments of Urology & Oncological Sciences, Mount Sinai School of Medicine, New York, NY 10029-0751, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2196/jmir.1891DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3846339PMC
January 2012
6 Reads
11 Citations
3.430 Impact Factor

Effect of radiotherapy planning complexity on survival of elderly patients with unresected localized lung cancer.

Int J Radiat Oncol Biol Phys 2011 Nov 6;81(3):706-11. Epub 2010 Oct 6.

Brookdale Department of Geriatrics and Adult Development, Mount Sinai School of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2010.06.060DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3020995PMC
November 2011
11 Reads
4 Citations
4.260 Impact Factor

Update on prostate brachytherapy: long-term outcomes and treatment-related morbidity.

Curr Urol Rep 2011 Jun;12(3):237-42

Florida Cancer Physicians Network, Florida Radiation Oncology Group, 717 West Robertson Street, Brandon, FL 33511, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11934-011-0183-3DOI Listing
June 2011
29 Reads
4 Citations

Young men have equivalent biochemical outcomes compared with older men after treatment with brachytherapy for prostate cancer.

Int J Radiat Oncol Biol Phys 2010 Aug 13;77(5):1315-21. Epub 2010 Jan 13.

Department of Radiation Oncology, Mount Sinai School of Medicine, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2009.06.052DOI Listing
August 2010
8 Reads
8 Citations
4.260 Impact Factor

Do high radiation doses in locally advanced prostate cancer patients treated with 103Pd implant plus external beam irradiation cause increased urinary, rectal, and sexual morbidity?

Brachytherapy 2010 Apr-Jun;9(2):114-8. Epub 2009 Oct 30.

Department of Urology, Mount Sinai School of Medicine, New York, NY 10075, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brachy.2009.08.002DOI Listing
June 2010
7 Reads
1 Citation
1.990 Impact Factor

Local control following permanent prostate brachytherapy: effect of high biologically effective dose on biopsy results and oncologic outcomes.

Int J Radiat Oncol Biol Phys 2010 Feb 23;76(2):355-60. Epub 2009 Jul 23.

Department of Urology, Mount Sinai School of Medicine, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2009.01.078DOI Listing
February 2010
4 Reads
12 Citations
4.260 Impact Factor

Does neoadjuvant hormonal therapy improve urinary function when given to men with large prostates undergoing prostate brachytherapy?

J Urol 2010 Feb 16;183(2):634-9. Epub 2009 Dec 16.

Departments of Urology, Mount Sinai School of Medicine, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2009.09.084DOI Listing
February 2010
6 Reads
4 Citations
4.471 Impact Factor

Outcomes for patients with high-grade prostate cancer treated with a combination of brachytherapy, external beam radiotherapy and hormonal therapy.

BJU Int 2009 Dec 2;104(11):1631-6. Epub 2009 Jun 2.

Departments of Radiation Oncology and Urology, Mount Sinai School of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2009.08661.xDOI Listing
December 2009
7 Reads
8 Citations
3.533 Impact Factor

Radiotherapy Planning Complexity and Survival after Treatment of Advanced Stage Lung Cancer in the Elderly.

Cancer 2009 Oct;115(20):4865-4873

Brookdale Department of Geriatrics and Adult Development, Mount Sinai School of Medicine, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.24512DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3058408PMC
October 2009
3 Reads
6 Citations
4.890 Impact Factor

Radiation dose predicts for biochemical control in intermediate-risk prostate cancer patients treated with low-dose-rate brachytherapy.

Int J Radiat Oncol Biol Phys 2009 Sep 14;75(1):16-22. Epub 2009 Mar 14.

Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2008.10.071DOI Listing
September 2009
11 Reads
8 Citations
4.260 Impact Factor

Prognostic significance of 5-year PSA value for predicting prostate cancer recurrence after brachytherapy alone and combined with hormonal therapy and/or external beam radiotherapy.

Int J Radiat Oncol Biol Phys 2009 Jul 10;74(3):753-8. Epub 2008 Dec 10.

Department of Radiation Oncology, Mount Sinai Hospital, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2008.08.049DOI Listing
July 2009
3 Reads
11 Citations
4.260 Impact Factor

There is no correlation between erectile dysfunction and dose to penile bulb and neurovascular bundles following real-time low-dose-rate prostate brachytherapy.

Int J Radiat Oncol Biol Phys 2009 Apr 14;73(5):1468-74. Epub 2008 Oct 14.

Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY 10029-6574, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2008.06.1946DOI Listing
April 2009
3 Reads
3 Citations
4.260 Impact Factor

Distant and local recurrence in patients with biochemical failure after prostate brachytherapy.

Brachytherapy 2008 Jul-Sep;7(3):217-22

Department of Radiation Oncology, Mount Sinai School of Medicine, 1184 5th Avenue, New York, NY 10025, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brachy.2008.04.002DOI Listing
November 2008
4 Reads
3 Citations
1.990 Impact Factor

TGFB1 single nucleotide polymorphisms are associated with adverse quality of life in prostate cancer patients treated with radiotherapy.

Int J Radiat Oncol Biol Phys 2008 Mar 8;70(3):752-9. Epub 2007 Aug 8.

Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2007.05.023DOI Listing
March 2008
8 Reads
14 Citations
4.260 Impact Factor

Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinoma.

Cancer 2008 Feb;112(3):535-43

Department of Radiation Oncology, Mount Sinai School of Medicine, New York, New York 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.23206DOI Listing
February 2008
29 Reads
9 Citations
4.890 Impact Factor

Stereotactic radiosurgery for thoracic malignancies.

Ann Thorac Surg 2008 Feb;85(2):S785-91

Department of Radiation Oncology, Mount Sinai School of Medicine, New York, New York 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2007.10.101DOI Listing
February 2008
3 Reads
2 Citations
3.850 Impact Factor

Brachytherapy for the treatment of prostate cancer.

Cancer J 2007 Sep-Oct;13(5):302-12

Department of Radiation Oncology, The Mount Sinai School of Medicine, James J. Peters VA Hospital, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PPO.0b013e318156dcbeDOI Listing
January 2008
7 Reads
4 Citations
4.240 Impact Factor

(125)I monotherapy using D90 implant doses of 180 Gy or greater.

Int J Radiat Oncol Biol Phys 2008 Jan 5;70(1):96-101. Epub 2007 Nov 5.

Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2007.06.067DOI Listing
January 2008
7 Reads
3 Citations
4.260 Impact Factor

Possession of ATM sequence variants as predictor for late normal tissue responses in breast cancer patients treated with radiotherapy.

Int J Radiat Oncol Biol Phys 2007 Nov 22;69(3):677-84. Epub 2007 May 22.

Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2007.04.012DOI Listing
November 2007
26 Reads
15 Citations
4.260 Impact Factor

A genetically determined dose-volume histogram predicts for rectal bleeding among patients treated with prostate brachytherapy.

Int J Radiat Oncol Biol Phys 2007 Aug 9;68(5):1410-6. Epub 2007 May 9.

Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2007.02.052DOI Listing
August 2007
8 Reads
11 Citations
4.260 Impact Factor

Effect of low dose-rate prostate brachytherapy on the sexual health of men with optimal sexual function before treatment: analysis at > or = 7 years of follow-up.

BJU Int 2007 Aug;100(2):362-7

Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2007.07016.xDOI Listing
August 2007
6 Reads
5 Citations
3.533 Impact Factor

Assessment of postbrachytherapy sexual function: a comparison of the IIEF-5 and the MSEFS.

Brachytherapy 2007 Jan-Mar;6(1):26-33

Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brachy.2006.11.003DOI Listing
May 2007
6 Reads
2 Citations
1.990 Impact Factor

Is seminal vesicle implantation with permanent sources possible? A dose-volume histogram analysis in patients undergoing combined 103Pd implantation and external beam radiation for T3c prostate cancer.

Brachytherapy 2007 Jan-Mar;6(1):38-43

Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brachy.2006.09.003DOI Listing
May 2007
9 Reads
2 Citations
1.990 Impact Factor

Early use of a phosphodiesterase inhibitor after brachytherapy restores and preserves erectile function.

BJU Int 2006 Dec;98(6):1255-8

Mount Sinai Medical Center, Urology, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2006.06441.xDOI Listing
December 2006
4 Reads
11 Citations
3.533 Impact Factor

Urinary symptom flare after brachytherapy for prostate cancer is associated with erectile dysfunction and more urinary symptoms before implantation.

BJU Int 2006 Nov;98(5):979-81

Department of Radiation Oncology, Mount Sinai Medical Center, New York 10029, USA.

View Article

Download full-text PDF

Source
http://stevenlehrer.com/images/bju06flare.pdf
Web Search
http://doi.wiley.com/10.1111/j.1464-410X.2006.06398.x
Publisher Site
http://dx.doi.org/10.1111/j.1464-410X.2006.06398.xDOI Listing
November 2006
5 Reads
3 Citations
3.533 Impact Factor

Low-dose rate prostate brachytherapy is well tolerated in patients with a history of inflammatory bowel disease.

Int J Radiat Oncol Biol Phys 2006 Oct 2;66(2):424-9. Epub 2006 Aug 2.

Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2006.05.027DOI Listing
October 2006
3 Reads
6 Citations
4.260 Impact Factor

Changing the patterns of failure for high-risk prostate cancer patients by optimizing local control.

Int J Radiat Oncol Biol Phys 2006 Oct;66(2):389-94

Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2006.05.072DOI Listing
October 2006
10 Reads
7 Citations
4.260 Impact Factor

Genetic predictors of adverse radiotherapy effects: the Gene-PARE project.

Int J Radiat Oncol Biol Phys 2006 Jul;65(3):646-55

Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2006.03.006DOI Listing
July 2006
37 Reads
25 Citations
4.260 Impact Factor

Disease-specific survival following the brachytherapy management of prostate cancer.

Int J Radiat Oncol Biol Phys 2006 Mar 23;64(3):810-6. Epub 2005 Nov 23.

Department of Radiation Oncology, Mount Sinai Hospital, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2005.09.005DOI Listing
March 2006
3 Reads
11 Citations
4.260 Impact Factor

ATM sequence variants and risk of radiation-induced subcutaneous fibrosis after postmastectomy radiotherapy.

Int J Radiat Oncol Biol Phys 2006 Mar 9;64(3):776-83. Epub 2005 Dec 9.

Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2005.09.014DOI Listing
March 2006
13 Reads
20 Citations
4.260 Impact Factor

Adjuvant radiation with modern techniques is the standard of care for stage III thymoma.

Ann Thorac Surg 2006 Mar;81(3):1180-1; author reply 1181-2

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2005.07.027DOI Listing
March 2006
1 Read
1 Citation
3.850 Impact Factor

Biologically effective dose values for prostate brachytherapy: effects on PSA failure and posttreatment biopsy results.

Int J Radiat Oncol Biol Phys 2006 Feb 19;64(2):527-33. Epub 2005 Oct 19.

Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2005.07.981DOI Listing
February 2006
2 Reads
27 Citations
4.260 Impact Factor

Urinary morbidity and incontinence following transurethral resection of the prostate after brachytherapy.

J Urol 2005 Mar;173(3):808-12

Department of Radiation Oncology, Mount Sinai School of Medicine, New York, New York 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.ju.0000152698.20487.0eDOI Listing
March 2005
78 Reads
8 Citations
4.471 Impact Factor

ATM sequence variants are predictive of adverse radiotherapy response among patients treated for prostate cancer.

Int J Radiat Oncol Biol Phys 2005 Jan;61(1):196-202

Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2004.09.031DOI Listing
January 2005
30 Reads
13 Citations
4.260 Impact Factor

Does prior transurethral resection of prostate compromise brachytherapy quality: a dosimetric analysis.

Int J Radiat Oncol Biol Phys 2004 Oct;60(2):648-53

Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2004.05.070DOI Listing
October 2004
4 Reads
2 Citations
4.260 Impact Factor

Combined modality treatment in the management of high-risk prostate cancer.

Int J Radiat Oncol Biol Phys 2004 Aug;59(5):1352-9

Department of Radiation Oncology, Mount Sinai School of Medicine, Box 1236, 1184 5th Avenue, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2004.01.023DOI Listing
August 2004
3 Reads
8 Citations
4.260 Impact Factor

Urinary symptom flare following I-125 prostate brachytherapy.

Int J Radiat Oncol Biol Phys 2003 Jul;56(4):1085-92

Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0360-3016(03)00210-4DOI Listing
July 2003
9 Reads
16 Citations
4.260 Impact Factor

Prostate-specific antigen bounce after prostate seed implantation for localized prostate cancer: descriptions and implications.

Int J Radiat Oncol Biol Phys 2003 Jun;56(2):448-53

Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0360-3016(02)04470-xDOI Listing
June 2003
5 Reads
16 Citations
4.260 Impact Factor